3 Monster Growth Stocks That Can Charge Forward in 2021

In This Article:

With 2020 winding down, there’s a growing belief that 2021 is going to be a growth year for the stock markets. The US elections have returned a divided government, one unlikely to have the broad majorities – or the broad support – needed to enact wide-ranging reform legislation from either the right or left, and that bodes well for the economy generally.

The COVID vaccines are entering distribution, and while new anti-virus lockdowns are also getting set in place, there’s a feeling that the end of the pandemic may be near.

According to the analyst community, a few names reflect serious growth plays. These are stocks that have already notched impressive gains year-to-date, and are poised to see the growth keep on coming even after 2020 wraps up.

Bearing this in mind, we used TipRanks’ database to scan the Street for tickers that fall into this category. Locking in on three in particular, the analysts believe that each name, which also happen to boast a “Strong Buy” consensus rating, can keep the rally alive in 2021.

SunOpta (STKL)

The first stock on this growth list is a health snack company, SunOpta. The company’s line of products includes plant-based beverages, fruit-based snacks, broth and stocks, teas, and sunflower and roasted snacks. The company markets through private label and co-manufacturing distribution, as well as through food service institutions.

SunOpta boasts a market cap of $962 million, after a year of stunning share price growth. The stock is up an impressive 328% this year, far outpacing the general markets.

The company’s Q3 revenues came in at $314.9 million, a 6.4% year-over-year gain. EPS, at a net loss of 1 cent, was better than the 2-cent loss expected – and far better than the 11-cent loss reported in the year-ago quarter.

The company’s solid performance has attracted the attention of Craig-Hallum analyst Alex Fuhrman. The analyst rates STKL a Buy along with a $15 price target. This figure implies a one-year upside of 40% from current levels. (To watch Fuhrman’s track record, click here)

Backing his stance, Fuhrman wrote, “We believe the company’s focus on high value plant-based foods and beverages should command a premium valuation with opportunities for upside to estimates as the economy recovers from COVID.”

In large part, Fuhrman’s optimism is based on SunOpta’s niche. The analyst noted, “We expect plant-based food stocks to command a premium valuation to other food companies for the foreseeable future given faster growth trends and compelling environmental benefits. At just $4.5B in sales today, plant-based products are less than 1% of the $695B grocery market, but it is easy to envision it representing a double-digit share of grocery sales over time.”